Login / Signup

Minimal impact of IL-17 and IL-12/23 inhibition on SARS-CoV-2/COVID-19 antibody response in psoriasis patients.

Leore LavinBenjamin UngarBrianna SaEmma Guttman-Yassky
Published in: Archives of dermatological research (2023)
Keyphrases
  • sars cov
  • end stage renal disease
  • coronavirus disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • peritoneal dialysis
  • prognostic factors
  • patient reported outcomes